Oruka Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2014 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Oruka Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2014 to Q4 2023.
  • Oruka Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $55.5M, a 2.13% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $55.5M +$1.16M +2.13% Dec 31, 2023 10-K 2024-02-01
Q4 2022 $54.4M +$2.25M +4.33% Dec 31, 2022 10-K 2024-02-01
Q4 2021 $52.1M +$5.13M +10.9% Dec 31, 2021 10-K 2023-02-24
Q4 2020 $47M +$2.36M +5.3% Dec 31, 2020 10-K 2022-03-14
Q4 2019 $44.6M +$1.1M +2.52% Dec 31, 2019 10-K 2021-03-18
Q4 2018 $43.5M +$1.9M +4.57% Dec 31, 2018 10-K 2020-02-18
Q4 2017 $41.6M -$13.2M -24% Dec 31, 2017 10-K 2019-02-27
Q4 2016 $54.8M +$6.16M +12.7% Dec 31, 2016 10-K 2018-03-22
Q4 2015 $48.6M +$4.12M +9.26% Dec 31, 2015 10-K 2017-03-21
Q4 2014 $44.5M Dec 31, 2014 10-K 2015-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.